Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wayman Wendell Cheatham
Observed names:
W. CHEATHAM,
W. Cheatham,
Wayman W Cheatham,
Wayman W. Cheatham
Observed institutions:
Howard University,
Howard University Hospital,
Prevention Group,
Takeda (United States),
Bureau of Medicine and Surgery,
United States Navy
show all 6
OpenAlex ID:
A5091828913
Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
2021
·
Christine G. Lee
, Brandy Heckman-Stoddard
, et al.
·
Diabetes Care
·
102
The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures
2020
·
Andrea M. Kriska
, Bonny Rockette-Wagner
, et al.
·
Diabetes Care
·
70
PDF
Peroxisome proliferator-activated receptor translational research and clinical experience
2009
·
Wayman Wendell Cheatham
·
American Journal of Clinical Nutrition
·
42
PDF
Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience
2022
·
Neil H. White
, Qing Pan
, et al.
·
Diabetes Care
·
34
PDF
The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact
2025
·
Jill P. Crandall
, Dana Dabelea
, et al.
·
Diabetes Care
·
28
PDF
Association of Metformin With the Development of Age-Related Macular Degeneration
2022
·
Amitha Domalpally
, Samuel A. Whittier
, et al.
·
JAMA Ophthalmology
·
25
Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP)
2022
·
Josephine H. Li
, James A. Perry
, et al.
·
Diabetes
·
20
PDF
Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH
2023
·
Josephine H. Li
, Laura N. Brenner
, et al.
·
Diabetologia
·
19
PDF
Patient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology
2023
·
Steve Edelman
, Wayman W. Cheatham
, et al.
·
Clinical Diabetes
·
18
PDF
HLA-DQ3 is Associated with Graves’ Disease in African-Americans
1996
·
M. H. Ofosu
, G. Dunston
, et al.
·
Immunological Investigations
·
18
Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure
2024
·
Christine G. Lee
, Adam Ciarleglio
, et al.
·
Diabetes Care
·
10
PDF
High Fructose Feeding Enhances Erythrocyte Carbonic Anhydrase 1 mRNA Levels in Rat
1997
·
K. K. GAMBHIR
, P. OATES
, et al.
·
Annals of the New York Academy of Sciences
·
10
Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks
2025
·
Emily Kobayashi
, Nathaniel J. Linden-Santangeli
, et al.
·
Diabetes Care
·
9
The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience
2022
·
Neil H. White
, Qing Pan
, et al.
·
Diabetes Care
·
8
PDF
TAP1 Polymorphism Identified in African-American Graves' Disease Patients
1998
·
M. H. Ofosu
, C. Brown
, et al.
·
Immunological Investigations
·
6
The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS)
2022
·
Marissa M. Shams-White
, Ashley H. Tjaden
, et al.
·
BMC Nutrition
·
5
PDF
The Tradition of Mentoring Part I: Mentoring the Researcher.
2010
·
Wayman W. Cheatham
·
Journal of Research Administration
·
5
Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes
2026
·
Marcel E. Salive
, Ashley H. Tjaden
, et al.
·
JAMA
·
3
Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS)
2025
·
Ashley H. Tjaden
, Barbara H. Braffett
, et al.
·
Diabetes Care
·
2
Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
2025
·
William H. Herman
, Adam Ciarleglio
, et al.
·
Diabetes Care
·
2
Dear Dr. Walson:
2001
·
N.Bradly Glazer
, Wayman Wendell Cheatham
·
Clinical Therapeutics
·
1
Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study
2025
·
Samuel Dagogo-Jack
, Erin J. Kazemi
, et al.
·
Diabetes Care
Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study
2025
·
William C. Knowler
, Qing Pan
, et al.
·
Diabetes Care
Patient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology
2023
·
Steve Edelman
, Wayman W. Cheatham
, et al.
PDF
Patient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology
2023
·
Steve Edelman
, Wayman W. Cheatham
, et al.
Show more works
View as search
Works count:
25
Citation count:
437
H-index:
10
I10-index:
12
Year
Topic
Type
